Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of P.J.G. Lisboa being referenced
p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P.J.G. Lisboa | 166 | 37 | 49 | 116 | 24 | 414 | |
| Nikolay Nagornov | 116 | 27 | 34 | 95 | 21 | 421 | |
| Zhengyu Zhao | 181 | 15 | 43 | 101 | 40 | 464 | |
| Charles Soussen | 32 | 13 | 70 | 88 | 36 | 494 | |
| Ryan R. Curtin | 107 | 27 | 49 | 62 | 13 | 483 | |
| W. L. Nicholson | 117 | 9 | 57 | 147 | 23 | 481 | |
| Fan Xu | 70 | 36 | 34 | 53 | 36 | 400 | |
| Konstantinos Blekas | 165 | 44 | 25 | 83 | 42 | 495 | |
| J. Martín | 115 | 24 | 28 | 34 | 37 | 493 | |
| J. M. Seixas | 55 | 61 | 78 | 39 | 53 | 417 | |
| Michael Mavroforakis | 265 | 44 | 37 | 219 | 11 | 511 |
All Works
Loading papers...